Angiography Equipment Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

Angiography Equipment Market Summary Introduction Angiography equipment comprises advanced diagnostic and interventional tools, including angiography systems, catheters, guidewires, balloons, contrast media, vascular closure devices, and accessories, used to visualize and treat cardiovascular conditions such as coronary artery disease (CAD), peripheral artery disease (PAD), and atherosclerosis. Deployed in hospitals, clinics, diagnostic centers, and research institutes, the market is driven by the rising global incidence of cardiovascular diseases, with the World Health Organization reporting 17.9 million annual deaths—32% of global mortality. Risk factors like hypertension, high cholesterol, diabetes, and smoking, particularly in low- and middle-income countries, fuel demand for angiography equipment to diagnose and treat vascular narrowing and blockages. An aging population, minimally invasive preferences, and technological innovations like 3D imaging and AI navigation further propel market expansion. Market Size and Growth Forecast The global angiography equipment market is projected to reach between USD 6.5 billion and USD 8.9 billion in 2025, with a compound annual growth rate (CAGR) of 5.2% to 7.1% through 2030, reflecting disease prevalence and technological advancements. Regional Analysis North America: The U.S. leads with high CAD rates and advanced diagnostics, while Canada focuses on minimally invasive solutions. Europe: Germany, France, and the UK dominate, driven by aging populations and strong healthcare systems. Asia Pacific: China and India see rapid growth due to rising cardiovascular risks, while Japan emphasizes elderly care technologies. Rest of the World: Brazil expands vascular care infrastructure, and the Middle East, notably the UAE, invests in premium equipment. Application Analysis Hospitals and Clinics: Projected growth of 5.0-6.8%, driven by interventional procedures. Trends focus on integrated systems. Diagnostic and Imaging Centers: Expected growth of 5.5-7.5%, linked to screening demands. Developments emphasize precision. Research Institutes: Growth at 4.8-6.5%, tied to innovation. Advances prioritize research capabilities. Type Analysis Angiography Systems: Anticipated growth of 5.5-7.5%, key for diagnostics. Trends focus on AI and 4K imaging. Catheters: Expected growth of 5.0-6.8%, essential for interventions. Advances enhance flexibility. Guidewire: Growth at 4.8-6.5%, aiding navigation. Developments prioritize precision. Balloons: Projected growth of 5.2-7.0%, for vessel dilation. Trends emphasize durability. Contrast Media: Growth at 5.0-6.8%, improving visualization. Advances focus on safety. Vascular Closure Devices: Expected growth of 5.5-7.5%, reducing recovery time. Trends highlight efficiency. Angiography Accessories: Growth at 4.5-6.5%, supporting procedures. Developments enhance compatibility. Key Market Players Key players include Siemens Healthineers, advancing imaging technologies; Philips, integrating AI solutions; GE Healthcare, offering robust systems; Canon Medical Systems, enhancing visualization; Medtronic, improving interventional tools; Shimadzu Corporation, innovating in efficiency; Angiodynamics, focusing on vascular solutions; Abbott, supporting patient outcomes; Microport Scientific Corporation, targeting affordability; B. Braun, providing reliable devices; and Cardinal Health, serving healthcare needs. These firms drive market growth through innovation. Porter's Five Forces Analysis Threat of New Entrants: Moderate, due to high R&D costs and regulatory barriers, though niche innovators can enter. Threat of Substitutes: Moderate, with alternative imaging like CT competing, though angiography offers unique interventional benefits. Bargaining Power of Buyers: Moderate, as hospitals seek cost-effective, high-efficacy equipment. Bargaining Power of Suppliers: Low, due to multiple component suppliers. Competitive Rivalry: High, with firms competing on imaging quality, radiation safety, and procedural efficiency. Market Opportunities and Challenges Opportunities: Cardiovascular diseases causing 17.9 million deaths annually drive demand. An aging population, growing to 2.1 billion by 2050, increases vascular needs. Minimally invasive preferences and innovations like Shimadzu’s 2024 SMART Voice and Philips’ AI-enhanced CT 5300 boost adoption. Emerging markets offer growth as healthcare systems modernize. Challenges: High equipment costs restrict access in low-income regions despite disease prevalence. Regulatory delays for new technologies pose hurdles. Competition from alternative diagnostics pressures market share. Market News In October 2024, Shimadzu unveiled SMART Voice for Trinias angiography systems, enhancing procedural efficiency. In June 2024, NIDEK introduced the RS-1 Glauvas OCT, improving retinal imaging. In February 2024, Philips launched the CT 5300 with AI, boosting diagnostic accuracy.